Stockreport

Revance Announces BELMONT Phase 2 Clinical Data to Be Presented at the 2017 American Academy of Dermatology (AAD) Annual Meeting

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF - Additional Presentation Affirms Use of Patient Questionnaires in Assessing Frown Lines - NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeut [Read more]